In MDS and CMML, there is a mixture of normal (white) and abnormal (brown) HSPCs. Brown color gradient represents the mutational burden. In both pre- and post-HMA treatment, the highly mutated HSPCs can differentiate and contribute to the peripheral blood, with slight variance in the clonal architecture. Professional illustration by Somersault18:24.